GLYCATED HEMOGLOBIN (HbA1C) ^

The Glycated Hemoglobin (HbA1C) test measures the proportion of haemoglobin chemically bound to glucose, providing a reliable estimate of average blood glucose control over the prior 2–3 months and serving as a key test for diagnosing and monitoring diabetes. Offered as a Lab‑at‑Home service in Dubai, it enables convenient in‑home sample collection—either finger‑prick or venous draw by a trained technician—so patients and clinicians can optimise medications, lifestyle measures and reduce long‑term cardiovascular and microvascular risk. Results are reported as a percentage (or mmol/mol), require no fasting, and should be reviewed with your healthcare provider in Dubai; inform the technician about recent transfusions or haemoglobin disorders as these can affect accuracy.

• Glycated Hemoglobin (HbA1C) (%)
• Glycated Hemoglobin (HbA1C) (IFCC, mmol/mol)
• Estimated Average Glucose (eAG) (mg/dL)

• Measures average blood glucose over the past 8–12 weeks to monitor long‑term control
• Used for diagnosis and routine management of Type 1 and Type 2 diabetes
• At‑home sample collection by certified phlebotomists across Dubai; no fasting required
• Processed in accredited UAE laboratories with numeric HbA1c and estimated average glucose (eAG)
• Results support medication optimisation, lifestyle adjustments and cardiovascular risk assessment

• Accurate measurement of average blood glucose over 2–3 months (HbA1c % and estimated average glucose)
• Ideal for diabetes diagnosis, routine monitoring, treatment adjustments and prediabetes screening
• Home sample collection across Dubai with trained phlebotomists and accredited laboratory analysis
• Fast digital results and downloadable report ready for your GP or endocrinologist in the UAE
• No fasting required; typically recommended every 3–6 months or as directed by your clinician

• At-home blood collection by certified phlebotomists across Dubai (finger‑prick or venous sampling as required)
• Accurate measurement of average blood glucose over the past 2–3 months; results reported as HbA1c (%)
• Used for diabetes diagnosis (ADA cutoff ≥6.5%) and routine monitoring to guide treatment adjustments
• Lab‑certified report compatible with UAE medical records and clinician follow‑up recommendations